Status:
COMPLETED
Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
H:S Laegeambulance
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
Brief Summary
The purpose of this study is to describe the efficacy and safety of prehospital administration of bivalirudin, as a substitute for heparin, in patients with acute myocardial infarction redirected for ...
Detailed Description
Primary angioplasty (pPCI) is the therapy of choice in patients with ST elevation acute myocardial infarction (STEMI) in Denmark. However, time is lost transferring patients from a local hospital to a...
Eligibility Criteria
Inclusion
- ST elevation acute myocardial infarction patients redirected for primary angioplasty
- Symptoms less than 12 hours
Exclusion
- Contraindications against primary angioplasty
Key Trial Info
Start Date :
November 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT00391326
Start Date
November 1 2006
End Date
April 1 2008
Last Update
May 21 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
H:S Lægeambulance
Copenhagen, V, Denmark, 1553
2
Rigshospitalet
Copenhagen, Ø, Denmark, 2100